Agility to Fight a Recession: Emerging Biopharma’s Secret Weapon
Zymewire
JANUARY 4, 2023
Agility to Fight a Recession: Emerging Biopharma’s Secret Weapon. Zymewire News
Zymewire
JANUARY 4, 2023
Agility to Fight a Recession: Emerging Biopharma’s Secret Weapon. Zymewire News
Fierce Pharma
JANUARY 4, 2023
Pfizer, GSK, AbbVie and many more celebrate New Year with price hikes: report. esagonowsky. Wed, 01/04/2023 - 10:21
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
JANUARY 6, 2023
Google and DeepMind have developed an artificial intelligence-powered chatbot tool called Med-PaLM designed to generate “safe and helpful answers” to questions posed by healthcare professionals and patients.
PharmaTech
JANUARY 3, 2023
Advancing the use of AI to understand the whole of a disease can reveal drug development insights that lead to drug discovery breakthroughs.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
This webinar will go over the FDA's guidance on pharmacological and toxicological considerations for optimizing doses for prescription drugs.
Medgadget
JANUARY 5, 2023
Researchers at the University of Florida have created a point-of-care biosensor that can rapidly detect a biomarker for oral cancer.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
pharmaphorum
JANUARY 6, 2023
The UK has formed an partnership with German biotech BioNTech to provide up to 10,000 patients with access to personalised cancer therapies, in another example of the country embracing the mRNA technologies that underpinned COVID-19 vaccines.
PharmaVoice
JANUARY 3, 2023
Durect’s chief medical officer altered his retirement plans to take a leading role at the company, which is developing a treatment for severe alcohol-associated hepatitis
Medgadget
JANUARY 6, 2023
Researchers at the National Eye Institute, which is part of the National Institutes of Health, have created a method to 3D bioprint eye tissue that forms the outer blood-retina barrier.
Fierce Pharma
JANUARY 4, 2023
Moderna makes its first-ever acquisition, buying Japanese DNA manufacturer OriCiro for $85M. mbayer. Wed, 01/04/2023 - 06:37
pharmaphorum
JANUARY 6, 2023
From enabling patient choice during clinical trials to strengthening vital partnerships across the quality ecosystem, connected data will become the lifeblood that enables life sciences teams to collaborate efficiently and effectively in 2023.
PharmaTech
JANUARY 2, 2023
CMOs are hoping to grow outsourcing to significantly higher levels in many different areas, with a focus on analytical testing, toxicity testing, and fill/finish operations.
Healthcare Success
JANUARY 3, 2023
I’ve noticed that most people tend to focus on only one of four variables when optimizing their digital marketing results. That’s a shame because true optimization requires a more strategic approach that considers each of the following four factors: Consumer Demand. Campaign Management (e.g.,
Fierce Pharma
JANUARY 3, 2023
Novartis pays $245M to settle Exforge generic pay-for-delay lawsuit. Tue, 01/03/2023 - 10:59
PharmExec
JANUARY 6, 2023
One company pursues a program for a technology they believe is a potential cure for Type 1 diabetes.
pharmaphorum
JANUARY 6, 2023
With the US economy teetering on a recession, sales and marketing budgets are expected to take a hit among businesses across sectors. The pharmaceutical industry is no exception.
PharmaTech
JANUARY 2, 2023
Inhaled vaccines must resist degradation and penetrate the mucosal lining in the airways and lungs.
Fierce Pharma
JANUARY 4, 2023
Particulates, label issues prompt separate recalls for Pfizer's Hospira and Accord. zbecker. Wed, 01/04/2023 - 11:35
PharmExec
JANUARY 4, 2023
Baker spoke on topics ranging from pricing, access, the war for talent, and other key areas that are impacting pharma companies.
pharmaphorum
JANUARY 5, 2023
The drive to make the UK a ‘scientific powerhouse’ was central to the government’s announcement closing out 2022 , which appointed five industry experts to lead on the sectors most vital to UK’s future innovation.
PharmaVoice
JANUARY 4, 2023
How charitable firms such as Advancium are helping to right the market wrongs of drug development
Fierce Pharma
JANUARY 6, 2023
With Leqembi approval in Alzheimer's disease, Eisai and Biogen plot 'meticulous' launch. fkansteiner. Fri, 01/06/2023 - 12:44
PharmExec
JANUARY 6, 2023
A chat with with Indegene's Timothy Moore, Senior Vice President, Emerging Biotech and Key Accounts and Jack Mycka, Vice President, Enterprise Medical Solutions and Emerging Biotech.
pharmaphorum
JANUARY 3, 2023
Encouraged by new data, Newron Pharmaceuticals has said it will start a registration study of would-be blockbuster evenamide in treatment-resistant schizophrenia (TRS) later this year.
Clear Pivot
JANUARY 5, 2023
Warmth, hospitality, and friendliness are all crucial for senior living communities. In fact, your success as a business depends on it.
Fierce Pharma
JANUARY 3, 2023
Lilly, Merck double down on peptide-targeted drug delivery, betting billions in biobucks on PeptiDream pacts. ntaylor. Tue, 01/03/2023 - 08:31
PharmExec
JANUARY 5, 2023
Using market access data from day one of your drug development and commercialization journey puts your brand in the best position to succeed at launch.
pharmaphorum
JANUARY 3, 2023
Research advises against aggressive cancer treatment at the end-of-life stages of the disease. At the same time, the pharmaceutical industry is creating a greater number of oncology treatments that could provide breakthroughs for patients where none previously existed.
PharmaVoice
JANUARY 5, 2023
As controversies abound and new drugs rise on the regulatory horizon, this year will be big for Alzheimer’s
Fierce Pharma
JANUARY 3, 2023
Unicycive's pivotal trial of rival to Takeda kidney drug hits main goal, clearing path to FDA filing. ntaylor. Tue, 01/03/2023 - 03:20
PharmaTech
JANUARY 5, 2023
The agency revised a regulation to enable pharmacies to dispense mifepristone directly to individuals with a prescription.
pharmaphorum
JANUARY 3, 2023
The way pharmaceutical companies manage data carries inherent risks, as exemplified by the constant scandals about data breaches. Is there anything that can be done about this?
PharmaVoice
JANUARY 5, 2023
Why Evernow CEO Alicia Jackson thinks menopause is the perfect inroad to helping women live longer lives
Fierce Pharma
JANUARY 6, 2023
Pfizer picks up steam in its pursuit of Merck's next-gen pneumococcal vaccine. kdunleavy. Fri, 01/06/2023 - 09:49
Let's personalize your content